Related to Illumina Acquires Genetic Abnormality Screening Firm

• 
• Cardiomyocyte-Beat Monitor
• Roche
• The xCELLigence RTCA Cardio Instrument provides predictive information about cardiac safety during drug development by measuring cardiomyocyte beating under physiological conditions in cell culture. Through noninvasive, real-time monitoring in 96-w
• 
• BRAF Mutation Detection
• Swift Biosciences
• myT BRAF-Ultra, an ultrasensitive version of myT BRAF, provides 0.01% sensitivity down to single-copy detection of BRAF mutations. myT BRAF-Ultra can detect less than 10 copies of mutant BRAF V600E/K with low breakthrough amplification from a backg
• 
• Compound Quality Control
• Brooks
• The Plate Auditor™ is a noninvasive tool for identification of precipitate and empty wells in compound and screening plates. The new Plate Auditor is the result of a collaboration with the Scripps Research Institute. It is designed to evaluate the
• 
• DNA Library Prep
• New England BioLabs
• The NEBNext® Ultra DNA Library Prep Kit for Illumina® contains enzymes and buffers that can convert a small amount of DNA input into indexed libraries for next-generation sequencing on the Illumina platform. The workflow of NEBNext Ultra
• 
• Microplate Detection Platform
• Molecular Devices
• The SpectraMax i3 platform’s base system features an integrated optical system enabling top and bottom reads for 6–384-well microplates and launches with three detection modes: luminescence, absorbance, and fluorescence. The user-exchangeable cartr